Motif Bio plc, of New York, said it filed a universal shelf registration statement with the SEC, which will enable the firm to sell, in one or more offerings, up to an aggregate of $80 million of ordinary shares, including American depositary shares, preference shares, warrants, subscription rights, debt securities and a combination of such securities, separately or as units.